INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Corporate insider
MM

Marquet Magda

DirectorCIK 0001631486

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
784 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    First Tracks Biotherapeutics, Inc.Director · Apr 22, 2026
9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A
—
11.0K sh
Apr 20, 2026
Apr 22, 2026
traded Apr 20, 2026
+2d
SEC FORM 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
9,200 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
10.6K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
16.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
16.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
5,500 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
6,030 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
4,000 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence